FAVIVIR is a product that contains drug Favipiravir. It is an oral antiviral medication that has exhibited positive clinical results and found to be useful in COVID-19 therapy following the approvals from the Drug Controller General of India (DCGI) through restricted medical use.
Favipiravir reduced body temperature and eliminated the virus out of the body half of the time as compared to the standard of care and improved the recovery rate in patients leading to earlier discharge from the hospital.
Favipiravir is used by doctors for the treatment of coronavirus disease 2019 (COVID-19). Currently, there is no approved product to treat COVID-19. Favipiravir is an investigational product and is considered for use in the treatment of Coronavirus infections.